Jiangsu Hengrui Pharmaceuticals (01276) repurchased 335,000 A shares for RMB 14.5036 million on September 17.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 17, 2026, it repurchased 335,000 A shares for RMB 14.5036 million.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 17, 2026, it repurchased 335,000 A shares for RMB 14.5036 million.
Related Articles
Henan Carve Electronics Technology (301182.SZ) controlling shareholder, actual controller, and others intend to transfer 5.6% of the company's shares by agreement.
Huatai (06886) issues RMB 1 billion corporate bonds.
Huatai (06886): "25Huatai C3" will pay interest on September 22.
Henan Carve Electronics Technology (301182.SZ) controlling shareholder, actual controller, and others intend to transfer 5.6% of the company's shares by agreement.
Huatai (06886) issues RMB 1 billion corporate bonds.
Huatai (06886): "25Huatai C3" will pay interest on September 22.
RECOMMEND
